Key Words: aldosterone Ⅲ AT 1 R Ⅲ AT 1a R Ⅲ AT 1b R Ⅲ intracellular signaling P athophysiological synergistic effects between angiotensin II (Ang II) and aldosterone have been described on vascular cells and support the concept that combination of aldosterone and Ang II receptor blockade may be therapeutically beneficial. [1] [2] [3] [4] In the past few years, investigators have demonstrated that blockade of mineralocorticoid receptor (MR) reduced mortality caused by progressive heart failure and sudden death from cardiac causes, as well as rate of hospitalization for heart failure. These results were observed in patients with severe heart failure who were also being treated with an angiotensin-converting enzyme inhibitor and included subjects developing heart failure after myocardial infarction. 5, 6 Growing evidence has shown that aldosterone could influence the signaling or trafficking of the Ang II type 1 receptor (AT 1 R). Indeed, mineralocorticoids such as deoxycorticosterone and aldosterone caused upregulation of Ang II binding to blood vessels and cultured VSMCs. 4, 7, 8 Spironolactone, a specific antagonist of MR, has been shown to inhibit Ang II-stimulated proliferation of VSMCs. 9 Recent studies have unraveled further evidence of a crosstalk between AT 1 R and MR. Ang II could directly stimulated nuclear localization of MR in human coronary and aortic VSMCs, supporting a role of MR in gene expression after Ang II stimulation. 10 Spironolactone also inhibits Ang II-induced senescence of VSMCs. These studies suggest that vascular responses to Ang II could be mediated via direct signaling crosstalk between MR and AT 1 R. 11 Among rodents, mice have 2 subtypes of AT 1 R, AT 1a R and Ang II type 1b receptor (AT 1b R). In the present study, we hypothesized that AT 1a R and AT 1b R interact differentially with MR to signal intracellularly. We sought to understand more precisely the molecular mechanisms underlying crosstalk between the 2 subtypes of AT 1 R present in the mouse, AT 1a R and AT 1b R, and MR. We focused on the effects that potential crosstalk had on activation of extracel-
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Methods

Cell Culture and Transfection
VSMCs derived from mesenteric arteries of 8 weeks male C57Bl/6 and AT 1a R knockout mice were isolated and characterized as described previously. 12, 13 AT 1a R knockout mice were produced at Duke University 14 and later bred in the animal facility at the Lady Davis Institute. Briefly, mesenteric arteries were cleaned of adipose and connective tissue and VSMCs were dissociated by the enzymatic digestion of vascular arcades. The tissue was filtered and the cell suspension centrifuged and resuspended in DMEM containing heatinactivated FBS, HEPES, L-glutamine, penicillin, and streptomycin. VSMCs were cultured in DMEM containing 10% FBS and maintained at 37°C in a humidified incubator (5% CO2/95% air). Early passage cells (passages 3 to 6) were used. Before experimentation, cells were rendered quiescent by serum deprivation for 24 hours. VSMCs were then transfected with a negative control small interference (si)RNA (luciferase) or siRNA (5 nmol/L) targeting AT 1a R, AT 1b R, or MR (Qiagen) and then stimulated with Ang II or aldosterone (10 Ϫ7 mol/L) after 48 hours in presence of siRNA. Where indicated, cells were also treated with losartan (10 Ϫ5 mol/L) or eplerenone (10 Ϫ5 mol/L) 30 minutes before stimulation with Ang II or aldosterone.
Quantitative RT-PCR
Efficiency of siRNA targeting AT 1a R, AT 1b R, and MR was verified by quantitative real-time polymerase chain reaction (QRT-PCR). VSMC RNA was isolated by homogenization in TRIzol reagent (Invitrogen) followed by chloroform extraction and isopropanol precipitation. One microgram of total RNA was reversed-transcribed with random hexamers and Superscript II (Invitrogen). QRT-PCR was performed using 2ϫ QuantiTect SYBR Green PCR Kit (Qiagen) with the Mx3005P (Stratagene) detection system. Each QRT-PCR sample was normalized to the expression of ribosomal protein S16 and is expressed as fold change in siRNA targeting AT 1a R-, AT 1b R-, or MR-treated samples compared to negative control siRNA samples. Primers were designed using Primer3 (Massachusetts Institute of Technology Center for Genome Research, Cambridge). Annealing temperature were 58°C to 61°C. Primers are described in Online Table I .
Western Blot
For Western blot analysis, VSMCs were homogenized in lysis buffer (final concentrations in PBS: 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mmol/L PMSF, 1 g/mL leupeptin, 1 g/mL aprotinin, 1 g/mL pepstatin, and 1 mmol/L NaVO 4 ). Lysates containing 30 g of protein were subjected to electrophoresis on polyacrylamide gels and transferred to nitrocellulose membranes. Membranes were incubated overnight with anti-phospho-ERK1/2, antiphospho-JNK, anti-phospho-NF-B p65, and anti-phospho-p38 mitogen-activated protein kinase (MAPK). Polyclonal antibodies for ERK2, JNK, NF-B p65, and p38MAPK antibody were used to reprobe blots to confirm equal loading in all lanes (Cell Signaling Technology). For preparation of nuclear extracts, VSMCs were first lysed in 1 mL of hypotonic buffer (20 mmol/L HEPES [pH 7.9], 20 mmol/L NaF, 1 mmol/L Na pyrophosphate, 1 mmol/L Na orthovanadate, 1 mmol/L EDTA, 1 mmol/L EGTA, 0.25 mmol/L Na molybdate and antiproteases cocktail) and the nuclear fraction was then extracted using a high-salt buffer (hypotonic buffer supplemented with 20% glycerol and 0.4 mol/L NaCl). Nuclear extracts were subjected to electrophoresis and incubated with anti-NF-B p65 antibody (Cell Signaling Technology). Monoclonal antibody for ␤-actin was used to reprobe blots (Sigma). An enhanced chemiluminescence system was used as the detection method (Pierce).
Ang II Measurement in Media Supernatant
Ang II levels in supernatant of VSMCs was evaluated with an ELISA kit according to the instructions of the manufacturer (AssayPro). Briefly, the kit uses a quantitative competitive sandwich enzyme immunoassay technique. A polyclonal antibody-specific for Ang II has been precoated onto a 96-well microplate. Ang II in standards and samples is competed by a biotinylated Ang II sandwiched by the immobilized antibody and streptavidin-peroxidase conjugate. All unbound Ang II is then washed away, and a peroxidase enzyme substrate is added. The color development is stopped and the color intensity measured (450 nm, Bio-Rad microplate spectrophotometer) (data not shown).
Fluorescent-Ang II Binding Assay
Cells were transfected with negative control or AT 1a R, AT 1b R, or MR siRNA 48 hours before treatment with 10 Ϫ7 mol/L aldosterone or Ang II for 20 minutes. Cells were then harvested and incubated 30 minutes at 37°C with Ang II-fluorescein isothiocyanate (FITC) (10 Ϫ8 mol/L) (Sigma) in a binding buffer containing in mmol/L (Tris 50 [pH 7.4], NaCl 100, KCl 5, MgCl 2 5, 0.25% BSA). VSMCs form AT 1a R-deficient mice were used as negative control. Preparations were then fixed with 2% PAF for 20 minutes and incubated with DAPI (3ϫ10 Ϫ7 mol/L, Invitrogen) before mounting.
Transfection of VSMCs and Luciferase Assay
VSMCs from C57Bl/6 and AT 1a R knockout mice were transfected with the mouse Ϫ360c-fos luciferase construct (kindly provided by T. Hoang 15 ) for 48 hours before incubation with either Ang II or aldosterone for 30, 60, or 120 minutes. Cells were lysed in lysis buffer containing 100 mmol/L Tris-HCl (pH7.9), 10% Igepal-P40, and 1 mmol/L dithiothreitol and incubated 15 minutes before luciferase activity measurements in triplicate (Orion II microplate luminometer, Berthold).
Statistical Analysis
Data are presented as meansϮSEM. Within-group differences were assessed with 1-way ANOVA. Post hoc comparisons were tested with the Newman-Keuls test. A value of PϽ0.05 was considered statistically significant.
Results
ERK1/2, NF-B, and JNK Activation by Aldosterone Requires a Functional AT 1 R
To evaluate the effect of aldosterone and Ang II on signaling pathways, we exposed VSMCs to aldosterone (10 Ϫ9 to 10 Ϫ7 mol/L was the only dose of aldosterone leading to activation of JNK ( Figure 1B ) and was used in subsequent experiments. siRNA was used to knockdown AT 1a R or AT 1b R in VSMCs to examine the effect on ERK1/2, JNK, NF-B, and p38MAPK activation. QRT-PCR with receptor-specific primers confirmed that transfection of AT 1a R-and AT 1b R-targeted siRNA resulted in 70% decrease of AT 1a R and 85% for AT 1b R mRNA by 48 hours after transfection. Expression of AT 1a R and AT 1b R mRNA was unchanged in presence of siRNA targeting MR. QRT-PCR for Ang II type 2 receptor (AT 2 R) showed that mRNA expression of AT 2 R was unchanged in all conditions ( Figure  3A ). The binding of Ang II-FITC was decreased in presence of the AT 1a R siRNA, and to a lesser extent after treatment with AT 1b R siRNA, but was unaffected by MR siRNA compared to the negative control ( Figure 3B ). Western blot experiments showed that AT 1a R knockdown blocked the activation of ERK1/2, JNK, NF-B, and p38MAPK (latter data not shown) induced by Ang II. Interestingly, AT 1a R knockdown abolished aldosterone-induced phosphorylation of ERK1/2, JNK, and NF-B. However, AT 1b R knockdown blunted aldosterone-induced NF-B activation but not ERK1/2 and JNK phosphorylation (Figure 4 ). Nuclear translocation of NF-B was also inhibited by the lack of AT 1a R and AT 1b R (Online Figure I) . The activation of p38MAPK in response to aldosterone was independent of the presence of an active AT 1a R. However, the response to Ang II required the presence of a fully active AT 1a R (data not shown). The role of AT 1 R in aldosterone-induced signaling pathways was confirmed by AT 1 R blockade with losartan. The phosphorylation of ERK1/2, JNK, and NF-B was indeed inhibited when cells were treated with losartan before stimulation with aldosterone or Ang II (Online Figure II) . These results implicate AT 1a R in some of the signaling pathways induced by aldosterone.
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NF-B Activation Requires Crosstalk Between AT 1 R and MR
Potential crosstalk between AT 1a R and MR in the regulation of ERK1/2, JNK, and NF-B activity was examined by knocking down MR using siRNA in C57Bl/6 VSMCs. Transfection efficiency was evaluated by QRT-PCR, which showed 75% knockdown of MR protein by 48 hours after transfection ( Figure 3A) . MR knockdown did not affect Ang II-or aldosterone-induced activation of ERK1/2 and JNK ( Figure 5 ) but abolished the phosphorylation ( Figure 5 ) and the nuclear translocation (Online Figure I) of NF-B induced by either Ang II or aldosterone. The absence of MR did not affect the activation of p38MAPK (data not shown). VSMCs were also treated with eplerenone, an MR-selective antagonist. Western blot showed that eplerenone had no effect on aldosterone-or Ang II-induced ERK1/2 activation. In contrast, we found that aldosterone-induced activation of JNK was blocked by eplerenone. Furthermore, the aldosterone-or Ang II-dependent phosphorylation of NF-B was reduced by eplerenone (Online Figure II) . These results suggest, on the one hand, that the activation of NF-B is tightly regulated by crosstalk between AT 1 R and MR in response to aldosterone and Ang II. On the other hand, they demonstrate that aldosterone stimulation requires a functional AT 1a R to induce activation of ERK1/2 independently of MR or partially dependent on MR for JNK activation. Ang II levels in the culture media were measured in the supernatant of VSMCs after knockdown of AT 1a R, AT 1b R, or MR after stimulation with vehicle, Ang II, or aldosterone for 20 minutes. Ang II was only detectable (ng/mL) in samples to which Ang II (10 Ϫ7 mol/L) has been added exogenously during 20 minutes (data not shown).
Aldosterone-Induced Genomic Effects Require a Functional AT 1a R
VSMCs from AT 1a R-deficient mice and wild-type littermates were transfected with luciferase reporter gene Ϫ360c-fos. The time course of activation of Ϫ360c-fos in cells from wild-type mice showed that both Ang II and aldosterone increased luciferase activity from 30 minutes to 1 hour. The luciferase activity returned to basal levels after 2 hours of aldosterone stimulation but continued to increase after 2 hours when stimulated with Ang II. Interestingly, the luciferase activity induced by aldosterone or Ang II was equivalent to basal levels at any time point in cells lacking AT 1a R ( Figure 6 ).
Discussion
In the present study, we demonstrate that VSMC activation of signaling pathways such as ERK1/2, JNK, and NF-B in response to aldosterone requires a functional AT 1a R. These results are supported at the genomic level by the finding that AT 1a R is also required for aldosterone-induced c-fos reporter gene activation. Growing evidence has demonstrated that Ang II and aldosterone may have pathophysiological synergistic effects on vascular cells. Ang II stimulates both systemic and local aldosterone production, whereas aldosterone can amplify Ang II effects by increasing the expression of angiotensin receptors 4 and angiotensin-converting enzyme. 16 Furthermore, the MR blocker spironolactone decreased cardiac hypertrophy, inflammation, and fibrosis induced by Ang II 17 and Ang II-mediated oxidative stress, endothelial dysfunction, and resistance artery structural remodeling. 18 Aldosterone causes both rapid, nongenomic, and genomic effects on cardiovascular function. Rapid signaling by aldosterone can be mediated through classical MR (ie, that can be inhibited by spironolactone or eplerenone), which potentiate Ang II/AT 1 R-mediated actions 19, 20 or through noncanonical MR, which have also been implicated in aldosterone/Ang II signaling. 19 Aldosterone synergistically augments ERK1/2 activation, JNK phosphorylation, Ki-ras2A induction, and oxidative stress, processes involved in VSMC growth, senescence, fibrosis, and inflammation. 11, 19 In agreement with those studies, our results demonstrated that aldosterone induced activation of ERK1/2, JNK, and NF-B through noncanonical and classical MR. We not only found that aldosterone and Ang II signaling crosstalk, but most importantly, that aldosterone signaling requires a functional AT 1a R. More importantly, these results were confirmed by pharmacological blockade of AT 1 R and MR, demonstrating the clinical relevance of the resulted from the present study. Several studies have suggested that Ang II and aldosterone in combination, at low or physiological doses, via AT 1 R and MR, induce the activation of ERK1/2 and c-Src, leading, respectively, to growth and migration of VSMCs. 11, 21 Mazak et al showed that in VSMCs from Sprague-Dawley rats, Ang II or aldosterone alone or in combination at higher concentration (10 Ϫ7 mol/L) induced the activation of ERK1/2 and JNK. Spironolactone treatment of VSMCs from SpragueDawley rats was able to reduce aldosterone-induced activation of ERK1/2 and JNK. 2 In the present study, we treated cells with relatively high concentrations of aldosterone, based on the fact that aldosterone levels as high as 10 Ϫ7 mol/L have been reported in individuals with congestive heart failure. 22, 23, 24 We found that high doses of Ang II or aldosterone increased the phosphorylation of ERK1/2, JNK, and NF-B. However, activation of ERK1/2 was independent of MR, and JNK activation was only partially dependent on MR, suggesting that aldosterone may bind to a plasma membrane MR different from that blocked by spironolactone as proposed by Wehling et al. 25 Differences between these results and those of Mazak et al may be explained in part by the use of different animal species (rat versus mouse). The use of siRNA in the present study may be more specific than spironolactone, which has been shown for example to also block glucocorticoid receptor. 2 Nonetheless, we demonstrate here for the first time that some aldosterone-induced signaling pathways require a functional AT 1a R. This effect is specific to ERK1/2, JNK, and NF-B pathways, as shown by the fact that aldosterone-induced activation of p38MAPK was not dependent on activity of AT 1a R.
Activation of ERK1/2 and JNK was independent of AT 1b R. In contrast, the activation of NF-B required the presence of a functional AT 1b R. The role of AT 1b R in the vasculature is poorly understood. This receptor subtype appears to have a more important role in the kidney and adrenal glands, where it has been shown to contribute to 20% of Ang II binding compared to 80% for AT 1a R. 26 However, Chen et al demonstrated that AT 1b R is an important component of AT 1 R mRNA in major mouse vessels, such as abdominal aorta and femoral artery. They found that the Ang II concentrationresponse curves in abdominal aorta and femoral artery were similar between AT 1a R-deficient and wild-type mice, suggesting that AT 1b R is able to maintain a normal Ang II response in the absence of AT 1a R. However, AT 1b R-deficient mice do not exhibit abnormalities in basal blood pressure. 27 The present is the first report to our knowledge demonstrating that the Ang II-induced activation of NF-B is mediated by both AT 1 R subtypes. Ϫ7 mol/L) in the presence of negative control siRNA (nϭ9). The same result was found for JNK phosphorylation in presence of the negative control siRNA (nϭ4 to 9). However, ERK1/2 and JNK activations were abolished in presence of siRNA targeting AT 1a R but not for AT 1b R (nϭ5 to 13 for ERK1/2 and nϭ4 to 6 for JNK). In parallel, aldosterone or Ang II also increased NF-B phosphorylation in presence of negative control siRNA (nϭ6 to 10). However, both AT 1a R and AT 1b R are required to induce the phosphorylation of NF-B in VSMCs treated with aldosterone or Ang II (nϭ9 to 11). *PϽ0.05 vs negative control (Neg CTRL)ϩvehicle; #PϽ0.05 vs AT 1b Rϩvehicle.
Ang II production by VSMCs after 20 minutes of aldosterone stimulation was undetectable, suggesting that aldosterone could transactivate AT 1a R, leading to increased phosphorylation of ERK1/2, JNK, and NF-B. This hypothesis was first proposed by Wehling et al, who showed unequivocal rapid effects of aldosterone that were neither mimicked by cortisol nor blocked by spironolactone, and postulated that these nongenomic effects were mediated by a plasma membrane receptor distinct from the classical MR. 25 Wildling et al recently identified specific aldosterone interaction sites on the endothelial cell surface structurally and functionally distinct from cytosolic receptors. These authors hypothesized that aldosterone interacts with a plasma membrane receptor site that mediates calcium influx into the cell cytosol. 28 Supporting this hypothesis, Yamada et al demonstrated that the vasoconstrictor effect of aldosterone is nongenomic and independent of classical MR and is not inhibited by spironolactone but by AT 1 R blockers. These investigators reported that aldosterone induced calcium-dependent activation of intracellular transglutaminase, leading to dimerization of AT 1 R and to its activation in a manner distinct from the activation induced by binding of Ang II. 29 Although we were unable to detect Ang II release by VSMCs in our experiments, this does not imply that blocking AT 1 R would not provide effective blockade of these aldosterone actions. Zou et al have shown that AT 1 R antagonists such as candesartan could still be effective in blocking the activation of AT 1 R even in the absence of Ang II. These investigators proposed that candesartan could act as an inverse agonist, that is, as an agent that stabilizes AT 1 R in an inactive conformation, thus suppressing its activation. 30 Mazak et al have suggested that the activation of ERK1/2 by Ang II and aldosterone modulates the expression of genes via phosphorylation of Elk-1, which controls the production of c-fos. 2 Jaffe and Mendelsohn demonstrated that Ang II-stimulated nuclear localization of MR, and spironolactone inhibited Ang II-mediated MR-dependent gene expression in VSMCs. Ang II-mediated MR activation was also inhibited by losartan, demonstrating a link between AT 1 R activation and MR transcriptional activation. These authors highlighted a specific role for MR independently of aldosterone. 10 In the present study, we questioned whether the AT 1 R is required for the genomic activity of aldosterone as it is for nongenomic rapid effects. In VSMCs from wild-type mice, aldosterone induced the activation of the c-fos promoter at 30 and 60 minutes, similar to what is found with Ang II. Aldosterone-induced c-fos promoter activation was blunted in VSMCs from AT 1a R knockout mice. These results strongly suggest that aldosterone also requires a functional AT 1a R to induce genomic effects, such as transcriptional activity of the c-fos promoter. These actions are consistent with the aldosterone-induced activation of ERK1/2 and JNK, which have been shown to increase the activation of AP-1 transcription factor. 31 Thus, our results may explain how aldosterone could influence the signaling of the AT 1a R and how it could mediate, in part, some of the classical cellular effects of Ang II. Finally, the present study has shown, to our knowledge for the first time, that aldosterone regulates AT 1a R-dependent gene expression.
Taken together, the results of the present study provide a partial mechanistic explanation of the signaling pathways induced by the activation of AT 1 R and MR. They also support the combined use of AT 1 R and MR antagonists in the treatment of cardiovascular disease, in particular in the context of hypertension, but also in heart failure. Further understanding of the molecular mechanisms by which aldosterone induces AT 1a R-dependent signaling and gene expression, and which are the genes that are most relevant for the vascular pathophysiological effects of aldosterone, may lead to the development of novel cardiovascular therapeutic strategies. Figure 4 , VSMCs were incubated for 48 hours with siRNA targeting MR, and phosphorylation of ERK1/2, JNK, and NF-B was examined. Phosphorylation of ERK1/2 and JNK in response to aldosterone or Ang II was also increased in presence of siRNA targeting MR (nϭ5 to 9), whereas activation of NF-B was blunted in presence of siRNA targeting MR compared to negative control (nϭ3 to 7). *PϽ0.05 vs negative control (Neg CTRL)ϩvehicle and §PϽ0.05 vs MRϩvehicle. Unfilled bars, vehicle; shaded bars, aldosterone; black bars, Ang II. Figure 6 . Aldosterone-induced c-fos gene transcription requires AT 1a R. Cell cultures were transfected with a luciferase reporter gene Ϫ360c-fos 48 hours before incubation with Ang II or aldosterone. Luciferase activity was increased by Ang II at 30 and 60 minutes in VSMCs from C57Bl/6 but abolished in VSMCs from AT 1a R knockout mice (nϭ3). *PϽ0.05 vs vehicle. Luciferase activity was increased by aldosterone at 30 and 60 minutes in VSMCs from C57Bl/6 but abolished in VSMCs from AT 1a R knockout mice (nϭ3). *PϽ0.05 vs vehicle.
